KRYS · CIK 0001711279 · FY2025 live · 2025-12-31
Krystal Biotech, Inc.
View as
Model
Classic Z
FY2025
7.95
Zone
Safe
Prior
—
Market DD
—
1y PD
—
Meridian Rank
97.55
0–100 · Classic Z tape · not a PD
Book standing
97
Year change
—
Market PD
—
O-score
99
Events on this name
Same published rows as Today. Not a live recompute.
Approaching grey
watch · 41
- Live Z: — → 7.95
- Cut: — → 1.80
7.95
Z″ 16.61
Score 7.95 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.691.2 × = 0.83X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
0.021.4 × = 0.03X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
0.123.3 × = 0.40X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
10.680.6 × = 6.41X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.291 × = 0.29
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Krystal Biotech, Inc. is on classic Z at 7.95 (safe) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Safe; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 95th percentile in Healthcare.
- IMRXSafeImmuneering Corp8.03
- MHUAFSafeMeihua International Medical Technologies Co., Ltd.8.18
- APUSSafeApimeds Pharmaceuticals US, Inc.8.19
- PMCBSafePharmaCyte Biotech, Inc.7.51
- UTHRSafeUNITED THERAPEUTICS Corp8.46
- SIONSafeSionna Therapeutics, Inc.8.47
- SGMTSafeSagimet Biosciences Inc.8.47
- DSGNSafeDesign Therapeutics, Inc.7.43
KPI widgets
Current assets
$1.0B
Total assets
$1.3B
Current liabilities
$103M
Total liabilities
$114M
Working capital
$922M
Retained earnings
$24M
EBIT
$161M
Total sales
$389M
Book equity
$1.2B
Accession 0001711279-26-000016. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.